Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Hepatocellular carcinoma (HCC) accounts for 90% of liver tumours and is one of the leading
causes of mortality. Cirrhosis due to viral hepatitis, alcohol or steatohepatitis is the major risk …

Background: Primary liver cancer, of which around 75–85% is hepatocellular carcinoma in
China, is the fourth most common malignancy and the second leading cause of tumor …

Standard for diagnosis and treatment of primary liver cancer (2022 edition) 中文|English ISSN
1001-5256 (Print) ISSN 2097-3497 (Online) CN 22-1108/R Home About Journal 1.Journal …

Purpose This guideline provides evidence-based recommendations for the indications and
technique-dose of external beam radiation therapy (EBRT) in hepatocellular carcinoma …

Purpose: This study aimed to evaluate the efficacy and safety of camrelizumab plus apatinib
with or without stereotactic body radiotherapy (SBRT) as first-line therapy for patients with …

In this study, an intelligent drug delivery system (DDS) based on implanted triboelectric
nanogenerator (iTENG) and red blood cell (RBC) is established for in situ hepatocellular …

Simple Summary The role of stereotactic body radiotherapy (SBRT), which can deliver high
radiation doses to focal tumors, has greatly increased in not only early-stage hepatocellular …

Aim To prospectively evaluate the efficacy and safety of stereotactic body radiotherapy
(SBRT) for patients with previously untreated solitary primary hepatocellular carcinoma …

Stereotactic body radiotherapy (SBRT), a type of external beam radiotherapy, yields local
control of hepatocellular carcinoma (HCC) at rates as high as 90%. SBRT has been …